5/15
11:44 am
ebs
Walgreens launches its own opioid reversal therapy for OTC use [Seeking Alpha]
Low
Report
Walgreens launches its own opioid reversal therapy for OTC use [Seeking Alpha]
5/15
09:58 am
ebs
Walgreens launches own brand of opioid overdose reversal drug [Reuters]
Low
Report
Walgreens launches own brand of opioid overdose reversal drug [Reuters]
5/15
09:54 am
ebs
Walgreens launches own brand of opioid overdose reversal drug [Yahoo! Finance]
Medium
Report
Walgreens launches own brand of opioid overdose reversal drug [Yahoo! Finance]
5/10
07:25 am
ebs
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 [Yahoo! Finance]
Low
Report
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 [Yahoo! Finance]
5/10
07:17 am
ebs
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
Low
Report
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
5/2
11:44 pm
ebs
Emergent Biosolutions lays off 300 people [Yahoo! Finance]
High
Report
Emergent Biosolutions lays off 300 people [Yahoo! Finance]
5/2
10:53 am
ebs
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
High
Report
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/1
11:57 pm
ebs
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
High
Report
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/1
05:06 pm
ebs
Emergent BioSolutions Reports First Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Emergent BioSolutions Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/1
04:57 pm
ebs
Emergent BioSolutions Reports First Quarter 2024 Financial Results
High
Report
Emergent BioSolutions Reports First Quarter 2024 Financial Results
5/1
04:21 pm
ebs
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position [Yahoo! Finance]
High
Report
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position [Yahoo! Finance]
5/1
04:10 pm
ebs
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
High
Report
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
5/1
11:09 am
ebs
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone [Yahoo! Finance]
Low
Report
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone [Yahoo! Finance]
5/1
11:03 am
ebs
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
Low
Report
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
4/30
05:26 pm
ebs
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
Low
Report
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
4/25
07:35 am
ebs
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength? [Yahoo! Finance]
High
Report
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength? [Yahoo! Finance]
4/24
11:07 am
ebs
FDA approves Amneal's generic version of OTC Narcan [Seeking Alpha]
Low
Report
FDA approves Amneal's generic version of OTC Narcan [Seeking Alpha]
4/24
08:07 am
ebs
Ascend Hires Scott Law as COO and Continues Strengthening Foundation [Yahoo! Finance]
Low
Report
Ascend Hires Scott Law as COO and Continues Strengthening Foundation [Yahoo! Finance]
4/22
08:05 am
ebs
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
Medium
Report
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
4/17
10:58 am
ebs
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses [Yahoo! Finance]
Low
Report
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses [Yahoo! Finance]
4/11
09:06 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Low
Report
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
3/28
08:28 am
ebs
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis [Yahoo! Finance]
3/28
08:15 am
ebs
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Medium
Report
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
3/25
10:11 am
ebs
National Safety Council Expands Efforts to Combat Overdoses in the Workplace [Yahoo! Finance]
Low
Report
National Safety Council Expands Efforts to Combat Overdoses in the Workplace [Yahoo! Finance]
3/25
08:16 am
ebs
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility [Yahoo! Finance]